Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

RIZAFILM

RIZATRIPTAN BENZOATE

Standard Dose
EQ 10MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview RIZAFILM is listed in Drugs@FDA under application 205394 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient RIZATRIPTAN BENZOATE Form and strength FILM;ORAL - EQ 10MG BASE Sponsor GENSCO Submission history Latest submission status date: 2026-02-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview RIZAFILM is listed in Drugs@FDA under application 205394 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient RIZATRIPTAN BENZOATE Form and strength FILM;ORAL - EQ 10MG BASE Sponsor GENSCO Submission history Latest submission status date: 2026-02-26 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.